April 12, 2023 -- Genomics company Cellecta announced on Wednesday that it has launched its DriverMap Adaptive Immune Receptor DNA (AIR-DNA) TCR and BCR kits that provide rapid, single-tube polymerase chain reaction (PCR) analysis of the variability of T-cell and B-cell receptor chains from a range of sample types, including tissue biopsy, whole blood, purified immune cells, and others.
The multiplex PCR assays use next-generation sequencing (NGS) to provide information on the variations within all four T-cell receptor (TCR) and all three B-cell receptor (BCR) chains in DNA samples.
Cellecta said in a statement that the new AIR-DNA assays complement their current AIR-RNA assays. Combined data from both the AIR-DNA and AIR-RNA assays gives a more comprehensive picture of the diversity and abundance of receptors and clonotypes activated in response to particular antigens -- information that is critical for understanding immune system responses to tumorigenesis, pathogens, and treatments or vaccines, for example.
As well as offering DriverMap AIR-DNA and AIR-RNA kits, Mountain View, CA-based Cellecta provides DriverMap AIR-DNA or AIR-RNA profiling as a service in which the firm provides quantitative clonotype data and an analysis report from immune-cell samples sent by researchers.
Copyright © 2023 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
